title: Coronary vasomotion dysfunction after everolimus-eluting stent implantation.
abstract: First generation drug-eluting stent can cause a paradoxical "in-segment" coronary vasoconstriction. This phenomenon was seen with sirolimus, paclitaxel, and, more recently, also with zotarolimus-eluting stent. For the first time, we describe a case of coronary-induced vasoconstriction by everolimus-eluting stents (EES).
authors.forename: Pietro
authors.initials: P
authors.lastname: Giudice
authors.forename: Tiziana
authors.initials: T
authors.lastname: Attisano
authors.forename: Marco
authors.initials: M
authors.lastname: Di Maio
authors.forename: Elisabetta M
authors.initials: EM
authors.lastname: Bellino
authors.forename: Maria V
authors.initials: MV
authors.lastname: Polito
authors.forename: Cesare
authors.initials: C
authors.lastname: Baldi
authors.forename: Francesco
authors.initials: F
authors.lastname: Vigorito
authors.forename: Michele R
authors.initials: MR
authors.lastname: Di Muro
authors.forename: Salvatore D
authors.initials: SD
authors.lastname: Tomasello
authors.forename: Alfredo R
authors.initials: AR
authors.lastname: Galassi
authors.forename: Federico
authors.initials: F
authors.lastname: Piscione
keywords: DES; coronary artery disease; coronary flow reserve; coronary spasm; everolimus-eluting stent